KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Inventory (2017 - 2025)

Guardant Health (GH) has disclosed Inventory for 9 consecutive years, with $85.9 million as the latest value for Q4 2025.

  • Quarterly Inventory rose 20.81% to $85.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $85.9 million through Dec 2025, up 20.81% year-over-year, with the annual reading at $85.9 million for FY2025, 20.81% up from the prior year.
  • Inventory hit $85.9 million in Q4 2025 for Guardant Health, down from $90.5 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $90.5 million in Q3 2025 to a low of $24.7 million in Q3 2021.
  • Historically, Inventory has averaged $58.9 million across 5 years, with a median of $62.5 million in 2023.
  • Biggest five-year swings in Inventory: fell 10.79% in 2021 and later soared 154.85% in 2022.
  • Year by year, Inventory stood at $30.7 million in 2021, then surged by 68.21% to $51.6 million in 2022, then rose by 20.06% to $61.9 million in 2023, then increased by 14.75% to $71.1 million in 2024, then increased by 20.81% to $85.9 million in 2025.
  • Business Quant data shows Inventory for GH at $85.9 million in Q4 2025, $90.5 million in Q3 2025, and $84.1 million in Q2 2025.